Q3 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | Theseus Pharmaceuticals, Inc. | $11,052,661 | -67.0% | 4,108,796 | +14.6% | 17.63% | -27.8% | |
| CMPX | Sell | Compass Therapeutics, Inc. | $2,456,545 | -41.7% | 1,246,977 | -5.8% | 3.92% | +27.4% |
| PHVS | Sell | Pharvaris N.V. | $691,674 | +33.8% | 33,142 | -2.9% | 1.10% | +192.1% |
| QSI | Exit | Quantum Si Inc | $0 | – | -924,404 | – | -1.21% | – |
| Exit | Somalogic, Inc. | $0 | – | -3,403,276 | – | -5.74% | – | |
| Exit | Pardes Biosciences Inc | $0 | – | -10,811,887 | – | -14.30% | – |
Q2 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HIMS | New | Hims & Hers Health, Inc. | $35,093,781 | – | 3,733,381 | – | 25.63% | – |
| New | Theseus Pharmaceuticals, Inc. | $33,451,278 | – | 3,585,346 | – | 24.43% | – | |
| New | Pardes Biosciences Inc | $19,569,515 | – | 10,811,887 | – | 14.30% | – | |
| ACRS | New | Aclaris Therapeutics, Inc. | $13,047,980 | – | 1,258,243 | – | 9.53% | – |
| New | Disc Medicine, Inc. | $10,811,977 | – | 243,513 | – | 7.90% | – | |
| KNTE | New | Kinnate Biopharma Inc. | $10,683,650 | – | 3,525,957 | – | 7.80% | – |
| New | Somalogic, Inc. | $7,861,568 | – | 3,403,276 | – | 5.74% | – | |
| CMPX | New | Compass Therapeutics, Inc. | $4,210,546 | – | 1,324,071 | – | 3.08% | – |
| QSI | New | Quantum Si Inc | $1,654,683 | – | 924,404 | – | 1.21% | – |
| PHVS | New | Pharvaris N.V. | $516,910 | – | 34,142 | – | 0.38% | – |
Q4 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PHVS | Exit | Pharvaris N.V. | $0 | – | -34,142 | – | -0.20% | – |
| ME | Exit | 23andMe Holding Co. | $0 | – | -406,913 | – | -0.90% | – |
| ENTA | Exit | Enanta Pharmaceuticals, Inc. | $0 | – | -42,250 | – | -1.68% | – |
| QSI | Exit | Quantum-Si Incorporated | $0 | – | -924,379 | – | -1.96% | – |
| GMTX | Exit | Gemini Therapeutics, Inc. | $0 | – | -2,435,125 | – | -3.07% | – |
| Exit | Invivyd, Inc. | $0 | – | -1,431,826 | – | -3.45% | – | |
| ACET | Exit | Adicet Bio, Inc. | $0 | – | -680,000 | – | -7.44% | – |
| CMPX | Exit | Compass Therapeutics, Inc. | $0 | – | -4,400,000 | – | -7.71% | – |
| Exit | Somalogic, Inc. | $0 | – | -3,516,472 | – | -7.84% | – | |
| KNTE | Exit | Kinnate Biopharma Inc. | $0 | – | -875,001 | – | -8.04% | – |
| Exit | Pardes Biosciences Inc | $0 | – | -9,400,515 | – | -13.37% | – | |
| HIMS | Exit | Hims & Hers Health, Inc. | $0 | – | -3,319,786 | – | -14.24% | – |
| Exit | Theseus Pharmaceuticals, Inc. | $0 | – | -3,335,346 | – | -14.87% | – | |
| ACRS | Exit | Aclaris Therapeutics, Inc. | $0 | – | -1,258,243 | – | -15.23% | – |
Q2 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | Pardes Biosciences Inc | $28,860,000 | – | 9,400,515 | – | 20.16% | – | |
| New | Theseus Pharmaceuticals, Inc. | $18,444,000 | – | 3,335,346 | – | 12.88% | – | |
| ACRS | New | Aclaris Therapeutics, Inc. | $17,565,000 | – | 1,258,243 | – | 12.27% | – |
| New | Somalogic, Inc. | $15,894,000 | – | 3,516,472 | – | 11.10% | – | |
| HIMS | New | Hims & Hers Health, Inc. | $15,039,000 | – | 3,319,786 | – | 10.51% | – |
| CMPX | New | Compass Therapeutics, Inc. | $11,660,000 | – | 4,400,000 | – | 8.15% | – |
| KNTE | New | Kinnate Biopharma Inc. | $11,034,000 | – | 875,001 | – | 7.71% | – |
| ACET | New | Adicet Bio, Inc. | $9,928,000 | – | 680,000 | – | 6.94% | – |
| New | Adagio Therapeutics, Inc. | $4,696,000 | – | 1,431,826 | – | 3.28% | – | |
| GMTX | New | Gemini Therapeutics, Inc. | $4,115,000 | – | 2,435,125 | – | 2.88% | – |
| QSI | New | Quantum-Si Incorporated | $2,145,000 | – | 924,379 | – | 1.50% | – |
| ENTA | New | Enanta Pharmaceuticals, Inc. | $1,997,000 | – | 42,250 | – | 1.40% | – |
| ME | New | 23andMe Holding Co. | $1,009,000 | – | 406,913 | – | 0.70% | – |
| PHVS | New | Pharvaris N.V. | $755,000 | – | 34,142 | – | 0.53% | – |
Q4 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LHDX | Exit | Lucira Health, Inc. | $0 | – | -485,000 | – | -0.24% | – |
| HLXA | Exit | Helix Acquisition Corp. | $0 | – | -250,000 | – | -0.77% | – |
| RACB | Exit | Research Alliance Corp. II | $0 | – | -500,000 | – | -1.53% | – |
| PHICU | Exit | Population Health Investment Co., Inc.unit | $0 | – | -960,000 | – | -1.74% | – |
| FSII | Exit | FS Development Corp. II | $0 | – | -602,500 | – | -1.86% | – |
| ME | Exit | 23andMe Holding Co. | $0 | – | -700,000 | – | -1.97% | – |
| PHVS | Exit | Pharvaris N.V. | $0 | – | -364,142 | – | -2.01% | – |
| HIMS | Exit | Hims & Hers Health, Inc. | $0 | – | -1,056,922 | – | -2.48% | – |
| GMTX | Exit | Gemini Therapeutics, Inc. | $0 | – | -2,435,125 | – | -3.06% | – |
| NRIX | Exit | Nurix Therapeutics, Inc. | $0 | – | -451,522 | – | -4.20% | – |
| Exit | Cue Health Inc. | $0 | – | -1,167,782 | – | -4.29% | – | |
| QSI | Exit | Quantum-Si Incorporated | $0 | – | -2,342,061 | – | -6.07% | – |
| KNTE | Exit | Kinnate Biopharma Inc. | $0 | – | -875,001 | – | -6.26% | – |
| ACRS | Exit | Aclaris Therapeutics, Inc. | $0 | – | -1,258,243 | – | -7.04% | – |
| Exit | Adagio Therapeutics, Inc. | $0 | – | -1,280,640 | – | -16.81% | – | |
| CGEM | Exit | Cullinan Oncology, Inc. | $0 | – | -2,731,410 | – | -19.16% | – |
| Exit | Somalogic, Inc. | $0 | – | -5,326,472 | – | -20.51% | – |
Q3 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | Somalogic, Inc. | $65,995,000 | – | 5,326,472 | – | 20.51% | – | |
| New | Adagio Therapeutics, Inc. | $54,094,000 | – | 1,280,640 | – | 16.81% | – | |
| New | Cue Health Inc. | $13,792,000 | – | 1,167,782 | – | 4.29% | – | |
| BCTG | Exit | BCTG Acquisition Corp. | $0 | – | -400,000 | – | -1.79% | – |
| ALXO | Exit | ALX Oncology Holdings Inc. | $0 | – | -231,200 | – | -4.97% | – |
| RLAY | Exit | Relay Therapeutics, Inc. | $0 | – | -400,000 | – | -5.76% | – |
Q2 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CGEM | New | Cullinan Oncology, Inc. | $70,334,000 | – | 2,731,410 | – | 27.67% | – |
| QSI | New | Quantum-Si Incorporated | $28,714,000 | – | 2,342,061 | – | 11.30% | – |
| ACRS | New | Aclaris Therapeutics, Inc. | $22,095,000 | – | 1,258,243 | – | 8.69% | – |
| KNTE | New | Kinnate Biopharma Inc. | $20,370,000 | – | 875,001 | – | 8.01% | – |
| GMTX | New | Gemini Therapeutics, Inc. | $15,755,000 | – | 2,435,125 | – | 6.20% | – |
| RLAY | New | Relay Therapeutics, Inc. | $14,636,000 | – | 400,000 | – | 5.76% | – |
| ALXO | New | ALX Oncology Holdings Inc. | $12,642,000 | – | 231,200 | – | 4.97% | – |
| NRIX | New | Nurix Therapeutics, Inc. | $11,979,000 | – | 451,522 | – | 4.71% | – |
| HIMS | New | Hims & Hers Health, Inc. | $11,510,000 | – | 1,056,922 | – | 4.53% | – |
| PHICU | New | Population Health Investment Co., Inc.unit | $9,744,000 | – | 960,000 | – | 3.83% | – |
| ME | New | 23andMe Holding Co. | $8,183,000 | – | 700,000 | – | 3.22% | – |
| PHVS | New | Pharvaris N.V. | $6,784,000 | – | 364,142 | – | 2.67% | – |
| FSII | New | FS Development Corp. II | $6,013,000 | – | 602,500 | – | 2.37% | – |
| RACB | New | Research Alliance Corp. II | $5,070,000 | – | 500,000 | – | 2.00% | – |
| BCTG | New | BCTG Acquisition Corp. | $4,552,000 | – | 400,000 | – | 1.79% | – |
| LHDX | New | Lucira Health, Inc. | $3,220,000 | – | 485,000 | – | 1.27% | – |
| HLXA | New | Helix Acquisition Corp. | $2,588,000 | – | 250,000 | – | 1.02% | – |